135 related articles for article (PubMed ID: 10406912)
1. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of two different evacuated tubes.
D'Angelo G; Villa C
Haematologica; 1999 Jul; 84(7):656-7. PubMed ID: 10406912
[No Abstract] [Full Text] [Related]
2. The use of evacuated tubes for blood collection in oral anticoagulant control.
van den Besselaar AM; van Halem-Visser LP; Loeliger EA
Thromb Haemost; 1983 Oct; 50(3):676-7. PubMed ID: 6648890
[TBL] [Abstract][Full Text] [Related]
3. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
Haematologica; 1985; 70(3):269-70. PubMed ID: 3932161
[No Abstract] [Full Text] [Related]
4. Laboratory monitoring of oral anticoagulant therapy.
Ginsberg JS; Hirsh J
Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
[No Abstract] [Full Text] [Related]
5. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
6. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
7. [Patients on anticoagulant therapy. Interpretation of a new test].
Benazzi A; Montebugnoli L
Dent Cadmos; 1991 Jan; 59(1):66-70. PubMed ID: 1828046
[TBL] [Abstract][Full Text] [Related]
8. [Oral anticoagulant administration].
Kiyose K; Fujita Y; Yamada T; Sakauchi H; Naka T
Rinsho Byori; 1974 Oct; 22(10 Suppl):113. PubMed ID: 4475723
[No Abstract] [Full Text] [Related]
9. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
Bailleul E; Van Vaerenbergh K; Lust A
Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
[No Abstract] [Full Text] [Related]
10. [Evaluation of prothrombin time and thrombotest and hepaplastin test for the control of oral anticoagulant therapy].
Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
Rinsho Byori; 1983 Feb; 31(2):210-4. PubMed ID: 6855001
[No Abstract] [Full Text] [Related]
11. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
12. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial.
van Aart L; Eijkhout HW; Kamphuis JS; Dam M; Schattenkerk ME; Schouten TJ; Ploeger B; Strengers PF
Thromb Res; 2006; 118(3):313-20. PubMed ID: 16182346
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
Katona A; Márk L
Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
[TBL] [Abstract][Full Text] [Related]
14. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
van Duuk-Wierda CA; Loeliger EA; Roos J
Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
[No Abstract] [Full Text] [Related]
15. Proceedings: Oral anticoagulant therapy and its control: an international survey.
Lam-Po-Tang PR
Thromb Diath Haemorrh; 1975 Sep; 34(1):362. PubMed ID: 1188826
[No Abstract] [Full Text] [Related]
16. [Peroral anticoagulant therapy--are the TT-values reliable?].
Eilertsen H; Asprang AF; Ulveland K; Nerdrum HJ
Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1690-2. PubMed ID: 9621756
[TBL] [Abstract][Full Text] [Related]
17. [Control of oral anticoagulant therapy. The Quick method is one step back].
Larson G; Stigendal L; Dahlbäck B; Berntorp E; Egberg N; Johnsson H
Lakartidningen; 1993 Aug; 90(34):2781. PubMed ID: 8366716
[No Abstract] [Full Text] [Related]
18. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America.
Hirsh J; Levine M
Thromb Haemost; 1988 Apr; 59(2):129-32. PubMed ID: 3291180
[No Abstract] [Full Text] [Related]
19. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulant drugs.
Ansell JE
N Engl J Med; 1992 Jan; 326(1):68; author reply 68-9. PubMed ID: 1727070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
